Could the recent buying interest simply be a realization that the first results from the Healios study will be coming out in about 90 days........and that this has an FDA priority designation........and that there were at least 2 peer reviewed articles last Winter lauding the science behind this stem cell treatment for stroke? If successful for stroke then cardiac will hopefully follow.....this could be a long term rocket ride and many want to get in on the first stage liftoff.......
No sellers again. Morning opening dip furiously bought again.
I anticipate ATHX to sign a lucrative partnership deal by year end with a large EU pharma company. When this news hits the tape the stock will trade with a $5 handle.
I've been in this stock for year and some folks are buying up a bunch of stock here folks. I dont think that would be happening if there wasn't some intel about positive news floating around out there. It smells too much like we should see some kind of news soon or we might see this sell off? Other possibility is that its not our little secret any more. Maybe its going up with all the other biotech seem to right now and its just accumulation by small cap hedge funds? My guess is news is a comin. Anybody care to chime in on this? :)
Some very interesting trading sessions each day in ATHX. This is third trading day recently in which we've seen a huge downward spike with volume in the first hour, only to see buyers pick the share price up quickly thereafter. (Insert your rationale here .... exiting shorts? institutions clamoring to slow the price rise? MMs taking out stops?)
I agree with a few posters that we may be short-term overextended, but with the recent volume levels it sure feels like there is breadth and depth to the base of buyers. Long and strong here.
good luck all ...
This stock is holding strong
It feels good to already be on the train and not trying to find an entry point to jump on board. This has been a long time waiting.
I believe a partnership is awaiting Congress' action on tax reform. If 100% business expensing is passed -- and there seems to be widespread momentum in that direction -- then R&D becomes a whole lot less costly, and a partner either will be in a position to give a lot more money to ATXH, or to take a much smaller cut of the final action. I think Congress knows it must deliver this win for President Trump and that it will happen before December. Then we may see a partnership -- a great one at that. Just my honest opinion.
The charts look like we have smooth sailing until 2.88 but its hard to use charts on this stock because the company has come along way since it hit 2.88 last then fell lower. So many potential catalyst that could pop and yet we dint have much resistance from a chart standpoint which is great news! I personally feel 3 buck will be a significant price point that we move through. Good job for all that have hung on. I have ALL y shares and I'm not looking to trade or sell any at these, still, ridiculously low prices. This stock should, at least be over 5 bucks for what its got going and thats a double from here!
Got our pre-10am "flush out" again today. Like a big glass of prune juice ....
MultiStem is much more than just stroke... Our Approach
We believe that MultiStem® could have broad relevance for treating acute neurological conditions and injuries, such as stroke, traumatic brain injury (TBI), neonatal hypoxic ischemia, and possibly spinal cord injury, as well as chronic neurological conditions that involve inflammation and neurodegeneration, such as Multiple Sclerosis and possibly Parkinson's disease. In preclinical studies, administration of MultiStem in various models of neurological injury has shown the potential to reduce inflammatory mediated damage, and enhance tissue repair and healing, such as promoting repair of the blood brain barrier.
Specifically, we believe that MultiStem may provide a benefit in certain neurological conditions in several ways, such as by protecting damaged or injured neurons, reducing inflammation, promoting formation of new blood vessels, and by augmenting tissue repair and healing. We are working with multiple independent labs to evaluate the potential application of MultiStem in a range of neurological conditions.
6 million shorts are recovering their oosition. clevlamd clinic is where all kings and presidents of all countries go , to get opereated on. im sure this helps. i heard on bloomberg news 2 months ago about football players bring helped by this drug , then i purchased 3k ,on borrowed money.
I'm back in the black for the first time in a couple of years.
Help. I cannot get into Seeking Alpha articles even tho I'm registered. Suggestions?
Stock is being manipulated down so far today - look for surge late in the day - $3 next week imo!
only scam here is Harold and I muted him
Harold the jokester posts that ATHX has less than 5 million in cash and massive debt - ATHX has no debt and a lot more cash!
sec just released quarterly sales of shares by execs effective 9/17. all four sold between 5-13,000 shares on 9/17 for prices around $2.22. all scheduled sales set up in advance as required by law. no big deal as they acquired a huge number in june. get some cash to pay the tax.
We just licked $2.50 and Harold's tongue is stuck to the flag pole